UK government funds AI software for lung cancer

Post author:Rhiannon Lassiter
Post published:July 9, 2021
Post category:Media

Healthcare IT news has included a story about Optellum in its news roundup.

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
J&J teams up with Optellum to improve lung cancer survival rates
Optellum collaborating with J&J
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.

You Might Also Like

101 Best United Kingdom Medical Device Startups

Client company Optellum announces strategic collaboration with Johnson & Johnson

Optellum collaborating with Johnson & Johnson